At present, our company has 8 preparation production lines, and the existing dosage forms include API, tablet, hard capsule, granule, small volume injection (including non sterile small volume injection), lyophilized powder injection and large infusion.
At present, the solid preparation production line and API······
Hubei Meilin Pharmaceutical Co., Ltd. was completed and put into production
Hubei Meilin Pharmaceutical Co., Ltd. was established in April 2010. It is a diversified compound pharmaceutical production company with self-research, production and sales, and joint research, production and sales. It is mainly engaged in the research and development and production of chemical raw materials and preparations. ,Sales.
News analysis: Where did you go to find the new crown drug?
Medical Network, August 24th: Although the new crown vaccine has been vaccinated in many countries on a large scale, the global epidemic is still continuing. The challenge of the mutated virus to the vaccine has also made scientists aware of the urgency of developing therapeutic drugs. Recently, the World Health Organization launched the "Unity Test+" project to find new crown treatment drugs in a new stage, and some research teams have also announced new developments in research and development.
End of the pilot, innovation and start again
Medical Network News on August 23 As soon as the pilot work of traditional Chinese medicine formula granules ended, a new wave of innovation surged across the face. According to data from the Public Opinion Monitoring Center of China Health Media Group: On February 10 this year, the State Food and Drug Administration and the State Administration of Traditional Chinese Medicine jointly issued the "Announcement on Ending the Pilot Work of Chinese Medicine Formula Granules" (hereinafter referred to as the "Announcement") , Decided to end the pilot work of traditional Chinese medicine formula granules, and clarified the supervision matters after the pilot work. After the announcement of the "Announcement", various provincial drug regulatory authorities have successively issued the working procedures for formulating the quality standards of traditional Chinese medicine formula granules and the requirements for application materials, and the implementation rules have been issued in many places to actively implement the requirements of the "Announcement", and the policy of traditional Chinese medicine formula granules has accelerated.
The list of key monitoring drugs may be adjusted every two years, and 30 varieties will be included
Medical Network News on August 23. Following the start of a new round of adjustments to the medical insurance catalogue and repeated news about the adjustment of the basic medicine catalogue, the key monitoring drug catalogue is also about to be adjusted. The catalogue previously included 20 varieties, which may reach 30 after the adjustment. Varieties.
Offline supervision of pharmacies and cross-departmental “joint inspections” in many places
Pharmaceutical Net News on August 20: The supervision of pharmacies has changed, and cross-departmental joint inspections have become a national trend. Medical insurance designated pharmacies, inter-departmental joint supervision On August 17, the People's Government of Fenghua District, Ningbo City issued the "Notice on the Inter-departmental Joint Inspection of Designated Retail Pharmacies" (hereinafter referred to as the "Notice").
R&D internal volume and admission rate is only 25%! How to reconstruct the pattern of innovative drugs under the New Deal?
Medical News, August 20: On July 2, the Center for Drug Evaluation (CDE) of the State Food and Drug Administration issued the "Clinical Value-Oriented Anti-tumor Drug Clinical Development Guidelines" for soliciting comments (hereinafter referred to as the "Guiding Principles"). One stone caused a thousand waves of waves, and the capital market responded strongly, and the pharmaceutical stock index fell for many days. "Moutai in Medicine" Hengrui Medicine has fallen from the throne of the pharmaceutical stock market value, ranking behind the leading medical device Mindray Medical and the leading pharmaceutical outsourcing service WuXi AppTec. This policy is tantamount to bringing an "ice bucket challenge" to the burgeoning Chinese innovative medicine industry.
More than 1,600 public hospitals in China's Internet hospitals become the main force for construction
Medical Network News on August 19: On the 18th, the "2021 Internet Doctors' Diagnosis and Treatment Behavior and Happiness Report" (hereinafter referred to as the report) jointly released by JD Health United Health (hereinafter referred to as the report) shows that doctors are actively embracing Internet medical treatment. According to the report, public hospitals are becoming the main force in the construction of Internet hospitals, accounting for nearly 70%. Among them, in tertiary hospitals and above, the proportion of doctors who choose to practice online on the Internet medical platform is about 30% to 40%.
The Differential Development of Specialty Pharmacies in China and America
In May of this year, the National Medical Insurance Administration and the National Health Commission issued the "Guiding Opinions on Establishing and Improving the "Dual Channel" Management Mechanism for Drugs in National Medical Insurance Negotiations". Uniform payment policy for medical institutions. The promulgation of this policy will greatly promote the development of professional pharmacies in China.
New regulations for long prescriptions! Biological agents are not excluded, and the issuance of long prescriptions shall not be affected on the grounds of cost control and the proportion of medicines!
Medical Network News on August 13: On August 12, the Medical Administration and Hospital Administration of the National Health Commission issued the "Notice on Printing and Distributing Long-term Prescription Management Standards (Trial)" (hereinafter referred to as "standards"). The “Specifications” clarify the applicable subjects of long-term prescriptions, medical institutions that issue long-term prescriptions, and the main procedures for issuing long-term prescriptions. According to the needs of patients for diagnosis and treatment, the amount of prescriptions for long-term prescriptions is generally within 4 weeks; according to the characteristics of chronic diseases, the condition is stable. The patient is appropriately extended, no more than 12 weeks.
Exhibition News | Zhisaila·Hospital Intelligent Robots at the 39th Zhongyuan Medical Equipment Exhibition, the highlights are different
CWMEE Central Plains Medical Exhibition is hosted by the Henan Medical Device Industry Association. It is a professional exhibition based on professional supporting operation services and a huge professional buyer information database. It is rooted in the Central Plains and radiates across the country. The scope of exhibits at this exhibition covers more than a dozen medical equipment sections, such as disinfection and control, operating room, first aid, and epidemic prevention materials. The hot scenes of participating in the grand event also demonstrate the inexhaustible vitality of the industry.
Diversified compound pharmaceutical production enterprise
Plant facilities meeting GMP requirements and sound quality management system
10 + million yuan
Hubei Merrill Lynch Pharmaceutical Co., Ltd., established in April 2010, is a diversified compound pharmaceutical production enterprise with self research, self production and self marketing, joint research, joint production and independent sales. It is mainly committed to the R & D, production and sales of chemical APIs and preparations. The company insists on introducing the quality risk management system from the product R & D stage, runs the quality management through the whole product life cycle, and ensures the continuous and stable production of safe, effective and qualified drugs. It has 8 preparation production lines, and the existing dosage forms include API, tablet, hard capsule, granule, small volume injection (including non terminally sterilized small volume injection), lyophilized powder injection and large infusion. At present, the solid preparation production line and API (trippidil, aminophenanthroline, topidone hydrochloride, delandro hydrochloride and methyl salicylate) have passed the GMP certification······
Company address：No. 8 Heping Road, Economic Development Zone, Yunmeng County, Xiaogan, Hubei Postal code：432500 This website supports IPV6
Filing information：鄂公网安备42092300000000号 鄂ICP备20010943号-1 《Internet information service qualification certificate》No. (E) - non operating-2020-0023
Operation information: the website has been running for 00001 days. It is recommended to use the browser based on chromium core to browse the website at a resolution of no less than 1920 * 1280px to obtain good browsing effect.
Merriclin Official Website
Merriclin WeChat Official